

UAB Weight Loss Medicine operates as part of the University of Alabama at Birmingham health system, bringing academic medical center resources to weight management in Birmingham, AL. Under the direction of Dr. Laura Rogers, a board-certified obesity medicine physician, the clinic applies evidence-based protocols to address excess weight as a chronic metabolic condition rather than a willpower issue. Patients access both in-person appointments at the Birmingham campus and telehealth consultations, allowing flexibility for those across Alabama who require specialized obesity care. The clinic integrates pharmacotherapy, nutrition counseling, and behavioral modification into individualized treatment plans designed for sustainable results.
Dr. Rogers prescribes GLP-1 receptor agonist peptides including semaglutide and tirzepatide for patients who meet clinical criteria based on body mass index and comorbid conditions such as type 2 diabetes, hypertension, or sleep apnea. Semaglutide mimics the incretin hormone GLP-1 to reduce appetite and slow gastric emptying, while tirzepatide activates both GLP-1 and GIP receptors for dual-pathway metabolic effects. These peptides are administered via weekly subcutaneous injection, with dosing titrated over several months to minimize gastrointestinal side effects and optimize weight reduction. The clinic monitors patients through regular follow-up visits that track body composition changes, metabolic markers, and medication tolerance, adjusting treatment intensity based on individual response and any emerging health concerns.
As a board-certified obesity medicine specialist, Dr. Rogers completed additional fellowship training beyond her medical degree to understand the complex neuroendocrine, genetic, and environmental factors that drive weight gain. Her clinical approach addresses underlying metabolic dysfunction rather than focusing solely on calorie restriction. Patients undergo comprehensive evaluation including metabolic lab panels, body composition analysis, and assessment of eating behaviors and physical activity patterns. This diagnostic phase identifies specific barriers to weight loss—such as insulin resistance, thyroid dysfunction, or medication-induced weight gain—that require targeted intervention. The clinic's affiliation with UAB provides access to interdisciplinary resources including registered dietitians, exercise physiologists, and behavioral health specialists when patients need coordinated care for complex cases.
New patients begin with an initial consultation that reviews medical history, previous weight loss attempts, current medications, and personal goals. Dr. Rogers explains how GLP-1 therapies work at the cellular level, sets realistic expectations for the rate and magnitude of weight loss, and discusses potential side effects such as nausea or constipation. Patients receive detailed instructions on injection technique, proper medication storage, and strategies to manage common adverse effects through dietary adjustments. Follow-up visits occur monthly during the active weight loss phase, then transition to quarterly maintenance appointments once target weight is achieved. The clinic emphasizes that peptide therapy functions as one component of a broader lifestyle modification program; patients work with nutrition staff to develop sustainable eating patterns and receive guidance on incorporating regular physical activity appropriate to their current fitness level.
UAB Weight Loss Medicine offers telehealth appointments for established patients and for initial consultations when in-person evaluation is not immediately necessary, expanding access for residents in rural Alabama communities or those with mobility limitations that make travel to Birmingham difficult. Prescriptions are sent electronically to the patient's preferred pharmacy, and the clinic coordinates with specialty pharmacies when insurance authorization is required for GLP-1 medications. Patients can message the clinical team through the UAB patient portal with questions about medication side effects, dosing schedules, or concerns between scheduled visits. The clinic accepts most major insurance plans and verifies coverage for obesity medicine services and peptide prescriptions during the scheduling process, providing cost estimates before treatment begins so patients understand their financial responsibility.
Laura Rogers· MD
Karen Harrison, MEd, RD, CDCES, LD
Dietetics
Anna Marchant, CRNP
Bariatric Medicine
Laura Rogers, MD
Internal Medicine
Antoinette Spellmon, CRNP
Bariatric Medicine
Amy Warriner, MD
Endocrinology
Basma Abdulhadi, MD
Endocrinology
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


